Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore

NCT02425098 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
351
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda